Skip to main content
SpringerLink
Log in

The Performance Enhanced: Clinical Relationships Between Performance- and Image-Enhancing Drugs, Physical Exercise and Mental Disorders

  • Chapter
  • First Online:
Emerging Drugs in Sport

  • 688 Accesses

Abstract

Mental health professionals can face multifaceted circumstances in which novel compounds, such as performance- and/or image-enhancing drugs, (PIEDs) and novel forms of behavioural addictions interact with pre-existing biological, psychological and social vulnerability factors, leading to psychopathological manifestations. This chapter explores how dysfunctional forms of physical activity may in some cases have a role in this complex phenomenon. It presents three clinical case reports showing a strong connections between mental disorders, sport-related habits, behavioural/substance addictions and use of PIEDs.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. McVeigh J, Evans-Brown M, Bellis MA (2012) Human enhancement drugs and the pursuit of perfection. Adicciones 24:185–190

    Article  Google Scholar 

  2. Rowe R, Berger I, Copeland J (2016) No pain, no gainz? Performance and image enhancing drugs, health effects and information seeking. Drugs: Education, Prevention and Policy, pp 1-9

    Google Scholar 

  3. Bersani FS et al (2015) Adverse Psychiatric Effects Associated with Herbal Weight-Loss Products. Biomed Res Int 2015:120679

    PubMed  PubMed Central  Google Scholar 

  4. Napoletano F et al (2020) The Psychonauts’ World of Cognitive Enhancers. Front Psychiatry 11:546796

    Article  Google Scholar 

  5. Corazza O et al (2014) “Spice,” “kryptonite,” “black mamba”: an overview of brand names and marketing strategies of novel psychoactive substances on the web. J Psychoactive Drugs 46:287–294

    Article  Google Scholar 

  6. Bersani FS, Imperatori C (2018) Misuse, recreational use, and addiction in relation to prescription medicines. In: Corazza O, Roman-Urrestarazu A (eds) Handbook of Novel Psychoactive Substances. Routledge, New York

    Google Scholar 

  7. Simonato P et al (2018) Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey. Hum Psychopharmacol 28:324–331

    Article  Google Scholar 

  8. Schifano F, et al (2019) New emerging psychoactive substances and associated psychopathological consequences. Psychol Med 2019:1–13

    Google Scholar 

  9. Schifano F et al (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:15–26

    Article  Google Scholar 

  10. Treasure J, Duarte TA, Schmidt U (2020) Eating disorders. Lancet 395:14–20

    Article  Google Scholar 

  11. Freimuth M, Moniz S, Kim SR (2011) Clarifying exercise addiction: differential diagnosis, co-occurring disorders, and phases of addiction. Int J Environ Res Public Health 8:4069–4081

    Article  Google Scholar 

  12. Bjornsson AS, Didie ER, Phillips KA (2010) Body dysmorphic disorder. Dialogues Clin Neurosci 12:221–232

    Article  Google Scholar 

  13. Quittkat HL et al (2019) Body dissatisfaction, importance of appearance, and body appreciation in men and women over the lifespan. Front Psychiatry 10:864

    Article  Google Scholar 

  14. Leone JE, Sedory EJ, Gray KA (2005) Recognition and treatment of muscle dysmorphia and related body image disorders. J Athl Train 40:352

    PubMed  PubMed Central  Google Scholar 

  15. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing

    Book  Google Scholar 

  16. Mosley PE (2009) Bigorexia: bodybuilding and muscle dysmorphia. Eur Eat Disord Rev 17:191–198

    Article  Google Scholar 

  17. Longobardi C et al (2017) Muscle dysmorphia and psychopathology: Findings from an Italian sample of male bodybuilders. Psychiatry Res 256:231–236

    Article  Google Scholar 

  18. Cerea S et al (2018) Muscle dysmorphia and its associated psychological features in three groups of recreational athletes. Sci Rep 8:8877

    Article  Google Scholar 

  19. Corazza O et al (2019) The emergence of Exercise Addiction, Body Dysmorphic Disorder, and other image-related psychopathological correlates in fitness settings: A cross sectional study. PLoS One 14:e0213060

    Article  CAS  Google Scholar 

  20. NHS Website (2020) Anabolic steroid misuse. Available from: https://www.nhs.uk/conditions/anabolic-steroid-misuse/#:~:text=Do%20a%20combination%20of%20both,before%20starting%20the%20cycle%20again

  21. Strakowski SM et al (2000) The impact of substance abuse on the course of bipolar disorder. Biol Psychiatry 48:477–485

    Article  CAS  Google Scholar 

  22. Bryson EO, Silverstein JH (2008) Addiction and substance abuse in anesthesiology. Anesthesiology 109:905–917

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Science, University of Hertfordshire, Hatfield, Hertfordshire, UK

    Pierluigi Simonato

  2. Dual Diagnosis Unit, Clinica Parco dei Tigli, Padua, Italy

    Pierluigi Simonato, Angela Scoppettone & Silvia Rossato

  3. Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy

    Francesco Saverio Bersani

Authors
  1. Pierluigi Simonato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Scoppettone
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francesco Saverio Bersani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvia Rossato
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Pierluigi Simonato .

Editor information

Editors and Affiliations

  1. Science and Medicine Department, World Anti-Doping Agency (WADA), Montreal, QC, Canada

    Olivier Rabin

  2. Department of Clinical, Pharmaceutical and Biological Sciences, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, Hertfordshire, UK

    Ornella Corazza

Rights and permissions

Reprints and permissions

Copyright information

© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Simonato, P., Scoppettone, A., Bersani, F.S., Rossato, S. (2022). The Performance Enhanced: Clinical Relationships Between Performance- and Image-Enhancing Drugs, Physical Exercise and Mental Disorders. In: Rabin, O., Corazza, O. (eds) Emerging Drugs in Sport. Springer, Cham. https://doi.org/10.1007/978-3-030-79293-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-79293-0_11

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-79292-3

  • Online ISBN: 978-3-030-79293-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation